Navigation Links
Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil,,Its New Long Acting Drug For Erectile Dysfunction

icantly (p<0.001) higher compared to 31% in the placebo group. Fifty percent (50%) of the patients in the 150mg group shifted to normal erectile function (EF domain scores >25) after 12 weeks on drug compared to 14% in the placebo group. All three active dose levels were well-tolerated; the most frequently reported adverse events were nasal congestion, flushing and headache and were mostly mild to moderate in intensity. No myalgia, back pain, leg pain or vision disturbances were reported and no serious adverse events related to the drug were reported. Only 4 patients withdrew from the study due to adverse events related to the drug.

Dong-A PharmTech Co., Ltd anticipates that the completion of the phase 2b trial will allow it to proceed with phase 3 clinical trials in the U.S. and Europe.

"We are extremely pleased with the results of this 340 patient phase 2b clinical trial in the U.S. which clearly demonstrated an excellent efficacy and safety profile in erectile dysfunction patients," stated Dong Hyun Park, President and CEO of Dong-A PharmTech. "The completion of this study is a major milestone in the development of udenafil. We plan to aggressively pursue regulatory approval in major markets throughout the world and to replicate in those markets the commercial success already achieved in Korea."

Udenafil was approved by the Korean FDA in November 2005 and launched by Dong-A Pharmaceutical in Korea under the brand name Zydena(R) in late December 2005 as the fourth entrant to the ED market. By the first quarter of 2006, Zydena(R) garnered 21% market share in Korea in terms of tablet volume and effectively expanded the Korean ED market volume by 16% through the introduction of new patients as well as re-entry of former patients. To date, Zydena(R) has maintained its market share, surpassing Levitra(R), and nearly reaching parity with Cialis(R) by sales volume.

Dong-A PharmTech Co., Ltd. has initiated the approval process for udenafil in C
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:7/28/2014)... RESTON, Va. , July 28, 2014 /PRNewswire/ ... management services, announced the Company has been awarded ... Medical Support Command (NEMSCOM) and its Deployable Medical ... to enable medical personnel to provide world-class healthcare ... any operating environment across the globe. The five ...
(Date:7/28/2014)... July 28, 2014  Array BioPharma Inc. (Nasdaq: ... the fourth quarter and full year of ... to discuss those results on Tuesday, August ... and Michael Carruthers , Chief Financial ... August 12, 2014Time:9:00 a.m. Eastern TimeToll-Free:(800) 708-4540Toll:(847) ...
(Date:7/28/2014)... July 28, 2014  Syneron Medical Ltd. (NASDAQ: ... announced today that its new PicoWay® device has received ... and colors and pigmented lesions on any skin type. ... with 532nm and 1064nm wavelengths, which utilizes Syneron,s proprietary ... pulses which are trillionths of a second, known as ...
Breaking Medicine Technology:Serco Awarded $22.7 Million Contract to Support Deployable Medical Systems 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 3Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 4
... very competitive market, healthcare providers are finding that ... Take Aria Health for example. It,s an innovative healthcare ... to live up to its reputation. But because its ... Eclipsys), still needed a complimentary system to handle unstructured ...
... NEW YORK, July 7, 2011 ... new market research report is available ... Lithotripters Market Outlook in BRICS (Brazil, ... 2017 http://www.reportlinker.com/p0567528/Lithotripters-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Devices ...
Cached Medicine Technology:Aria Health, Two More Healthcare Providers Choose OnBase for ECM 2Aria Health, Two More Healthcare Providers Choose OnBase for ECM 3Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 2Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 3Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 4Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 5Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 6Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 7Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 8Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 9Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 10Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 11Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 12Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 13Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 14Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 15
(Date:7/28/2014)... Braintree, Massachusetts (PRWEB) July 28, 2014 ... the Summit Provider Exchange technology solution ... office integration efforts and support collaboration with their ... 242 bed acute-care medical center located in New ... 800,000 seasonal visitors with a variety of inpatient ...
(Date:7/28/2014)... News) --,The more chronic medical conditions people have at ... a new study claims. Since nearly four ... at Johns Hopkins Bloomberg School of Public Health in ... in life expectancy are slowing in the United States. ... kidney disease and heart failure is now the norm ...
(Date:7/28/2014)... Steven Reinberg HealthDay ... People who have dementia and heart rhythm irregularities are more ... research has found. In fact, the study of more ... to 80 percent more likely to get a pacemaker than ... from this study is why folks with dementia are so ...
(Date:7/28/2014)... Parker Waichman LLP, a personal injury law firm that ... of 9/11 are never forgotten, comments that the September 11th ... to a VCF message dated July 3, 2014, ... before October 12, 2012 must file a Registration Form no ... were allegedly injured by the toxic dust cloud that hovered ...
(Date:7/28/2014)... LA JOLLAWhen you,re expecting somethinglike the meal you,ve ... interest, unique electrical rhythms sweep through your brain. ... and they reflect a symphony of cellsboth excitatory ... their role has been debated, gamma waves have ... in the patterns have been tied to schizophrenia, ...
Breaking Medicine News(10 mins):Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 3Health News:Chronic Medical Conditions Can Shorten Seniors' Lives: Study 2Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 2Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 3Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 3Health News:Memory relies on astrocytes, the brain's lesser known cells 2Health News:Memory relies on astrocytes, the brain's lesser known cells 3
... husband creates an extra seven hours a week of housework ... a nationally representative sample of U.S. families. , For men, ... about an hour of housework a week. , The findings ... on 2005 time-diary data from the federally-funded Panel Study of ...
... OAK BROOK, Ill., April 4, 2008 Guarding,wealth ... with high,net worth may not always have the ... they may have an inexperienced financial advisor who ... "Saving on current income taxes and minimizing ...
... e-mails to be read and the Internet links included ... design. Design pays off! Recipients are more likely to ... attractively. This also applies to important medical information sent ... conclusion reached in a study conducted at the Department ...
... of Adelaide, Australia, will delve into some of the crucial ... research, to be conducted in the joint University of Adelaide/IMVS ... chemical signals in the brain and the reasons why brain ... mysteries around how the brain works, and this new research ...
... Adults With ... Disabilities, ... of its 27th annual ,Cones for Kids, Valentine,s Day,fundraiser to benefit ... raised just over $616,000 to help,children and adults with disabilities in ...
... Southern California, LOS ANGELES, April 4, 2008 ... for $4 per prescription at,its stores in Southern California., ... generic drugs prescribed for,30-day supplies and will be available ... list of the participating pharmacies and,eligible generic drugs is ...
Cached Medicine News:Health News:Exactly how much housework does a husband create? 2Health News:Tax Planning Ideas: Sound Strategies Protect Wealth, Advises Whitnell & Co. 2Health News:E-mail design pays off 2Health News:Unlocking mysteries of brain cancer, stroke 2Health News:Friendly's Dishes Out $616,000 for Easter Seals 2Health News:Ralphs Introduces $4 Generic Drugs 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: